Transcription of Full Prescribing Information - NERLYNX
{{id}} {{{paragraph}}}
HIGHLIGHTS OF Prescribing Information These highlights do not include all the Information needed to use NERLYNX safely and effectively. See full Prescribing Information for NERLYNX . NERLYNX (neratinib) tablets, for oral use Initial Approval: 2017 _____ INDICATIONS AND USAGE _____ NERLYNX is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy. (1, 14) _____ DOSAGE AND ADMINISTRATION _____ Antidiarrheal prophylaxis: Initiate loperamide with the first dose of NERLYNX and continue during first 2 cycles (56 days) of treatment.
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE NERLYNX is indicated for the extended adjuvant treatment of adult patients with early stage
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Global Tax practice Tax Treatment of Additional, Features, The Personal Pension Account, The Personal Pension Account Series 1, Apex v5 Drawing Features Addendum 11-2012, 048480 Maestro Occupancy/Vacancy Sensor CL, Maestro ® Occupancy/ Vacancy Sensor CL, Additional, Document Library TS Data Sheet 08609, 1 Document Library TS Data Sheet 08609